Sionna Therapeutics, Inc. Common Stock SION Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $64.29M-23.2% | $59.41M+53.3% | $51.79M+41.1% | $41.95M-6.8% | $83.66M-0.1% | ||
| $220.96M-19.3% | $241.42M+59.9% | $252.33M— | $266.75M— | $273.68M— | ||
| $2.07M-13.5% | $2.23M-9.8% | $2.14M— | $2.25M— | $2.39M— | ||
| $73.78M-13.2% | $74.42M+263% | $76.67M— | $74.7M— | $85.02M— | ||
| $305.04M-17.5% | $325.95M+75.5% | $339.27M— | $352.05M— | $369.67M— | ||
| $2.11M-58.0% | $769K-35.2% | $1.48M+184% | $914K— | $5.02M+201% | ||
| $9.78M+2.6% | $11.71M+12.4% | $9.85M— | $7.55M— | $9.53M— | ||
| $16.83M-6.0% | $19.12M+0.1% | $17.6M— | $15.62M— | $17.91M— | ||
| 500M0.0% | 500M+9,999,900% | 500M— | 500M— | 500M— | ||
| -$283.13M-43.3% | -$256.35M-41.6% | -$235.91M— | -$215.64M— | -$197.57M— | ||
| $288.21M-18.1% | $306.83M+287% | $321.67M+317% | $336.43M+351% | $351.77M+379% | ||
| $305.04M-17.5% | $325.95M+75.5% | $339.27M— | $352.05M— | $369.67M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Sionna Therapeutics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 22.60 — current assets exceed current liabilities.
- Where does Sionna Therapeutics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.